Trump's Executive Action on Drug Supply Resilience
Published on: Aug. 14, 2025, 3:39 a.m. | Source: Devdiscourse
President Donald Trump signed a directive to bolster the U.S. drug supply chain by building the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). The Department of Health and Human Services will identify 26 crucial drugs for national security, ensuring readiness against shortages.
